Medication info
Impactwin Tablet 10/20mg

Impactwin Tablet 10/20mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
White to off-white, biconvex, rectangular tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201600974 · Approved 2016.02.22 · Insurance code 698503340

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg per day. The usual recommended initial dose is 10/20mg per day. Patients who require less LDL cholesterol reduction may start at 10/10mg per day. After starting this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease caused by hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is used in conjunction with dietary therapy to lower total cholesterol, LDL cholesterol, Apo B, and triglycerides while increasing HDL cholesterol in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial mixed hyperlipidemia. It is also administered as an adjunct therapy or when other treatments are difficult in patients with homozygous familial hypercholesterolemia to reduce total cholesterol and LDL cholesterol. This medication is used when appropriate dietary and non-drug treatments have not been effective in patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia, and the other causes of dyslipidemia should be identified and managed before treatment. To ensure effective treatment, lipid tests including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides are required, and further tests may be needed in patients with high triglyceride levels. This medication helps improve these lipid values, thereby reducing cardiovascular risk and maintaining a healthy blood lipid state.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg per day. The usual recommended initial dose is 10/20mg per day. Patients who require less LDL cholesterol reduction may start at 10/10mg per day. After starting this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication can cause serious muscle-related side effects such as myopathy and rhabdomyolysis, so patients should consult a doctor immediately if they experience symptoms such as muscle pain or weakness. This medication should not be used in patients with certain liver diseases or in patients who show abnormally high liver enzyme levels on blood tests. Women who are pregnant or nursing should not take this medication, and women planning to become pregnant should consult a doctor, and if pregnancy is confirmed, should stop taking it immediately. This medication should be avoided with strong CYP3A4 inhibitors such as certain antifungals, antibiotics, and HIV medications, as they can increase the risk of myopathy. Additionally, this medication should not be taken with drugs such as gemfibrozil, cyclosporine, or danazol, and patients must inform their doctors or pharmacists about other medications to avoid potential interactions. Elderly patients, those with hypothyroidism, and those with weakened kidney function may have an increased risk of myopathy when taking this medication, requiring additional caution. Regular liver function and muscle-related tests are recommended while taking this medication, and any unusual symptoms should be reported to healthcare providers immediately. Grapefruit juice may increase the blood concentration of this medication, raising the risk of side effects, so it should be avoided while taking it. Common side effects reported in clinical trials and post-market studies include headaches, diarrhea, muscle pain, and cold symptoms, while rare side effects may include liver damage, allergic reactions, and severe skin reactions. This medication is not recommended for children under 10 years, and adolescents over 10 should take it under medical supervision. In the case of overdose, there is no specific antidote, so patients should visit a medical institution immediately for appropriate treatment. Patients taking this medication must inform healthcare providers when prescribed new medications and should be cautious of drug interactions.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 98 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • systemic drug reaction with symptoms
  • erythema multiforme
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • oculomotor disorders
  • facial muscle weakness
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disturbances
  • memory impairment
  • forgetfulness
  • amnesia
  • memory disorders
  • confusion
  • interstitial lung disease
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated ɤ-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best kept at room temperature between 1°C and 30°C. Proper storage helps maintain the efficacy of the medication and prevent degradation.

Appearance and packaging

Appearance

White to off-white, biconvex, rectangular tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.